More about Procter & Gamble Hygiene and Health Care Limited
Fundamentals for Procter & Gamble Hygiene and Health Care Limited
Regulatory Filings for Procter & Gamble Hygiene and Health Care Limited
IndiGo Implements Steep Fuel Surcharge as Iran Conflict Sends Jet Fuel Costs Soaring
The RBI's New Forex Fortress: Defensive Maneuvers in an Era of Oil Shocks
India's Fiscal Milestone: GST Collections Breach ₹2 Lakh Crore Mark for the First Time
AI Disruption Accelerates: Oracle Layoffs Raise Alarms for India’s Tech Workforce
Fundamentals for Procter & Gamble Hygiene and Health Care Limited
Business Operations:
Sector: Consumer DefensiveIndustry: Household & Personal Products
Procter & Gamble Hygiene and Health Care Limited engages in the manufacture and sale of branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Healthcare Products and Hygiene Products segments. The company provides health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also offers baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home care products; and oral care products. The company offers its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brand names. It sells its products through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
Revenue projections:
With PGHH's revenues forecasted to be lower than last year's, investors are expected to be cautious. A decline in revenue typically harms the company's bottom line, reducing profitability and making investors less confident about the company's ability to sustain its financial health.
Financial Ratios:
| currentRatio | 1.370000 |
|---|---|
| forwardPE | 40.747444 |
| debtToEquity | 0.221000 |
| earningsGrowth | -0.010000 |
| revenueGrowth | 0.013000 |
| grossMargins | 0.624290 |
| operatingMargins | 0.239510 |
| trailingEps | 221.260000 |
| forwardEps | 27341.459000 |
PGHH's current ratio being 1.37 suggests that the company has no issue servicing its short-term debt. Its strong liquidity position, supported by sufficient cash reserves and current assets, ensures that PGHH can meet its financial obligations with ease.
PGHH's low earnings and revenue growth suggest that the company may face shrinking profits. This could indicate underlying financial challenges, making it difficult for PGHH to sustain its current profitability.
With positive gross and operating margins, PGHH's profitability is evident. These metrics suggest the company is efficiently managing its expenses while maintaining strong revenue, highlighting a solid financial foundation.
With Procter & Gamble Hygiene and Health Care Limited's forward EPS higher than its trailing EPS, the company is expected to be more profitable in the current financial year. This signals confidence in Procter & Gamble Hygiene and Health Care Limited's growth potential, as improved earnings are forecasted compared to the prior year's performance.
Price projections:
PGHH's price projections have been steadily revised down, pointing to declining confidence in the company's outlook. This suggests that analysts are becoming more conservative in their expectations for PGHH's future performance.
Recommendation changes over time:
PGHH has recently received a buy bias from analysts, indicating that the stock is being perceived as a favorable investment. This positive sentiment could encourage investors to see PGHH as a wise place to allocate their funds, potentially leading to increased interest in the company's stock.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
U.S. Labor Market in 2026: JOLTS and Consumer Confidence Reveal Why Hiring Cooled Without Unemployment Spike
Lending Unleashed: Assessing the Impact of the Federal Reserve’s Capital Rollback
Calendar Collision: How Mahavir Jayanti's Overlap With Fiscal Year-End Reshapes India's Tax-Loss Harvesting Landscape